Immune Function

Aging, stress and nutrition affect blood concentrations of anabolic hormones—modulating immune function. Discussions on the immune-endocrine loop during aging reflect the role of growth hormone and insulin-like growth factor-1. Review current research and medical articles on immune function and disease risk to stay informed.


Aging, Adiposity, and Calorie Restriction.pdf

This study concluded that calorie restriction in adult men and women causes beneficial metabolic, hormonal, and functional changes, but the precise amount of calorie intake or body fat mass associated with optimal health and maximum longevity in humans is not known. In addition, it is possible that even moderate calorie restriction may be harmful in specific patient populations, such as lean persons who have minimal amounts of body fat.
Fontana, L. & Klein, S. (2007). Aging, adiposity, and calorie restriction [Electronic version]. The Journal of the American Medical Association, 297(9), 986-994. Retrieved May 2, 2007.

Increased Lean Red Meat Intake Does Not Elevate Markers of Oxidative Stress and Inflammation in Humans.pdf

The aim of this study was to determine whether an increase in unprocessed lean red meat intake, partially replacing carbohydrate-rich foods, adversely influences markers of oxidative stress and inflammation. The results of this study suggest that partial replacement of dietary carbohydrate with protein from lean red meat does not elevate oxidative stress or inflammation.
Hodgson, J.M., Ward, N.C., Burke, V., Beilin, L.J. & Puddey, I.B. (2007). Increased lean red meat intake does not elevate markers of oxidative stress and inflammation in humans [Electronic version]. The Journal of Nutrition, 137(2), 363-367. Retrieved May 14, 2007.

Dietary Patterns Throughout Adult Life Are Associated with Body Mass Index, Waist Circumference, Blood Pressure, and Red Cell Folate.pdf – link not working

The objective of this study was to assess the relations between dietary patterns during adult life (at ages 36, 43, and 53 y) and risk factors for chronic disease at age 53 y. Participants of a longitudinal study of health completed a 5-d food diary at 3 occasions during adult life (n = 1265). Factor analysis was used to identify dietary patterns and a pattern score was calculated from the consumption of the food items in each dietary pattern.
McNaughton, S.A., Mishra, G.D., Stephen, A.M. & Wadsworth, M.E. (2007). Dietary patterns throughout adult life are associated with body mass index, waist circumference, blood pressure, and red cell folate [Electronic version]. The Journal of Nutrition, 137(1), 99-105. Retrieved May 14, 2007.

Fiber Crucial to Breast Health in Premenopausal Women.pdf

According to this article, researchers suggest that fiber may support health in premenopausal women because antioxidant nutrients in high-fiber foods have protective properties against reactive oxygen species. Another theory, they suggested, is that fiber may stabilize insulin levels in the body, since hyperglycemia may be a potential cause of cancer. Another theory why fiber may be important to breast health, they suggested, revolves around estrogen’s role in the development of breast cancer.
VRP Staff. (2007). Fiber crucial to breast health in premenopausal women [Electronic version]. Vitamin Research Products Website. Retrieved May 31, 2007.

NAMS Updates Recommendations on Diagnosis and Management of Osteoporosis in Postmenopausal Women.pdf

To address the need for standards of care as they relate to menopause-associated health conditions, the North American Menopause Society (NAMS) has updated its evidence-based guidelines on the diagnosis, prevention, and treatment of osteoporosis in postmenopausal women. The full report was published in the May/June 2006 issue of Menopause.
Armstrong, C. (2006, November 1). NAMS updates recommendations on diagnosis and management of osteoporosis in postmenopausal women [Electronic version]. American Family Physician, 74(9). Retrieved November 2, 2006.

High Carb, Low Glycemic Index Diet Best to Reduce CV Risk.pdf

Diets high in carbohydrates (CHOs) with low glycemic index (GI) are best for cardiovascular risk reduction, according to the results of a randomized controlled study reported in the July 24 issue of the Archives of Internal Medicine.
Barclay, L. (2006, July 25). High carb, low glycemic index diet best to reduce CV risk [Electronic version]. Medscape Medical News. Retrieved November 14, 2006.

Lowering Dietary Glycemic Load for Weight Control and Cardiovascular Health: A Matter of Quality.pdf

This study concludes that although significant differences in neurohormonal responses to different types of carbohydrates have long been recognized, until recently this knowledge has not been comprehensively and systematically applied to the study of diet and CVD in populations or to the development of food-composition tables in guiding dietary practice.
Liu. S. (2006). Lowering dietary glycemic load for weight control and cardiovascular health: a matter of quality [Electronic version]. Archives of Internal Medicine, 166(14), 1438-1439. Retrieved November 14, 2006.

Prevalence of Hypogonadism in Males Aged at Least 45 Years: The HIM study.pdf

According to this study, based on TT concentration, the prevalence of hypogonadism in men reporting to primary care offices was estimated to be 38.7%. The medical conditions that occurred significantly more frequently among hypogonadal men than eugonadal men included increased BMI, hypertension, hyperlipidaemia, diabetes, and asthma or COPD. As men age, they are susceptible to conditions that share many of the same symptoms similar to hypogonadism. The presence of these conditions may, in effect, mask underlying hypogonadism and negatively impact quality of life.
Mulligan, T., Frick, M.F., Zuraw, Q.C., Stemhagen, A. & McWhirter, C. (2006). Prevalence of hypogonadism in males aged at least 45 years: the HIM study [Electronic version]. International Journal of Clinical Practice, 60(7), 762-769. Retrieved November 27, 2006.

Association of Coffee and Caffeine Intake with the Risk of Parkinson Disease.pdf

The findings of this study indicate that higher coffee and caffeine intake is associated with a significantly lower incidence of PD. This effect appears to be independent of smoking. The data suggest that the mechanism is related to caffeine intake and not to other nutrients contained in coffee.
Ross, G.W., Abbott, R.D., Petrovitch, H., Morens, D.M., Grandinetti, A., Tung, K.H., et al. (2006). Association of coffee and caffeine intake with the risk of Parkinson disease [Electronic version]. The Journal of the American Medical Association, 283(20), 2674-2679. Retrieved November 27, 2006.

Low Serum Testosterone and Mortality in Male Veterans.pdf

This study used a clinical database to identify men older than 40 years with repeated testosterone levels obtained from October 1, 1994 to December 31, 1999, and without diagnosed prostate cancer.  It concluded that low testosterone levels were associated with increased mortality in male veterans. Further prospective studies are needed to examine the association between low testosterone levels and mortality.
Shores, M.M., Matsumoto, A.M., Sloan, K.L. & Kivlahan, D.R. (2006). Low serum testosterone and mortality in male veterans [Electronic version]. Archives of Internal Medicine, 166(15), 1660-1665. Retrieved August 28, 2006.

Vitamin E Supplementation Raised Chances of New Cancer in at-Risk Patients.pdf

Researchers have reported that cancer patients who took high-dose vitamin E supplements to protect themselves from a recurrence of the disease were actually at higher risk of getting a second cancer while taking the supplement than those in a placebo group.
Vitamin E supplementation raised chances of new cancer in at-risk patients. (2005). [Electronic version]. Nutraingredientsusa.com. Retrieved May 17, 2005.

Prostate Carcinoma Incidence in Relation to Prediagnostic Circulating Levels of Insulin-Like Growth Factor I, Insulin-Like Growth Factor Binding Protein 3, and Insulin.pdf

In this study, the IGF-1 level was not associated positively with the risk of prostate carcinoma; however, an increase in the IGFBP-3 level was associated with a modest decrease in risk.
Chen, C., Lewis, S.K., Voigt, L., Fitzpatrick, A., Plymate, S.R. & Weiss, N.S. (2005). Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin [Electronic version]. Cancer, 103(1), 76-84. Retrieved May 17, 2005.

Experts Consider HT for Younger Women.pdf

Questions still persist after the release of the July 2002 Women’s Health Initiative findings regarding hormone therapy.  Researchers have been looking at the data to see if certain changes in dosage or initiation age could still provide benefits to women.
Elliott, V.S., (2005, February 28). Experts consider HT for younger women [Electronic version]. American Medical News, pp. 19-20.  Retrieved April 28, 2005.

Abdominal Obesity a Better Marker of Insulin Resistance Syndrome. Insulin Resistance Syndrome Increases Risk for Metabolic Syndrome, Type 2 Diabetes, CVD and PCOS.pdf

According to Mary Ann Banerji, MD, associate professor of medicine and endocrinology at SUNY Downstate Medical Center in Brooklyn, N.Y., abdominal obesity may be a better marker of insulin resistance syndrome than other indicators such as BMI and weight.  Banerji spoke about obesity and its association with insulin resistance syndrome at the 65th Scientific Sessions of the American Diabetes Association.
Lewis, J. (2005). Abdominal obesity a better marker of insulin resistance syndrome. Insulin resistance syndrome increases risk for metabolic syndrome, type 2 diabetes, CVD and PCOS [Electronic version]. Endocrine Today, 3(8), 14.  (PDF)

Study Links Fat Distribution and Not Body Weight as an Indicator of Cardiovascular Disease Risk.pdf

GE Healthcare, a unit of General Electric Company (NYSE: GE), announced that the company’s Lunar Prodigy bone density system was used in a groundbreaking study to evaluate body composition and fat distribution in the body as an important indicator of risk of cardiovascular disease.  The study was presented at the 27th Annual Meeting of the American Society for Bone and Mineral Research meeting in Nashville, TN, September 23-27.
(2005, September 23). Study links fat distribution and not body weight as an indicator of cardiovascular disease risk [Electronic version]. (PDF)

Renal Arginine Metabolism.pdf

According to this review article, the kidney plays a major role in arginine metabolism in 3 principal ways: arginine synthesis, creatine synthesis, and arginine reabsorption. Appreciable quantities of arginine are synthesized in the kidney from citrulline produced by the intestine. The renal enzymes of arginine synthesis, argininosuccinate synthetase and argininosuccinate lyase, occur in the cells of the proximal tubule. The rate of arginine synthesis depends on citrulline delivery and does not appear to be regulated by dietary arginine availability. Renal arginine synthesis in humans produces approximately 2 g arginine/d, which may be compared to an intake, from a Western diet, of approximately 4 to 5 g/d.
Brosnan, M.E. & Brosnan, J.T. (2004). Renal arginine metabolism [Electronic version]. The Journal of Nutrition, 134(Suppl. 10), 2791S-2795S. Retrieved May 14, 2007.

Free Testosterone and Risk for Alzheimer Disease in Older Men.pdf

The results of a recent study revealed a link between low testosterone levels and potential for future onset of Alzheimer’s. Researchers found that men with Alzheimer disease had a lower testosterone level prior to the diagnosis. Future research results may offer protection against a diagnosis of Alzheimer disease in aging men. 
Moffat, S. D., Zonderman, A.B., Metter, E.J., Kawas, C., Blackman, M.R., Harman, S.M., et al (2004). Free testosterone and risk for Alzheimer disease in older men [Electronic version]. Neurology, 62, 188-193. Retrieved June 15, 2004.

Prospective Study of Postmenopausal Hormone Use and Newly Diagnosed Asthma and Chronic Obstructive Pulmonary Disease.pdf

This study concludes that postmenopausal hormone use was associated with an increased rate of newly diagnosed asthma but not newly diagnosed COPD. Female reproductive hormones may contribute to the onset of asthma among adult women, but do not appear to hasten the development of COPD.
Barr, R.G., Wentowski, C.C., Grodstein, F., Somers, S.C., Stampfer, M.J., et al. (2004). Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease [Electronic version]. Archives of Internal Medicine, 164(4), 379-386. Retrieved September 27, 2005.

Safety and Adverse Effects of Androgens: How to Counsel Patients.pdf

In short-term clinical trials of androgen replacement in women, several benefits have been shown, including improved libido, bone mineral density and body composition.  While androgen therapy for women is relatively new, it is receiving more attention.
Basaria, S. & Dobs, A.S. (2004). Safety and adverse effects of androgens: how to counsel patients [Electronic version]. Mayo Clinic Proceedings, 79(4 Suppl.), S25-32. Retrieved May 18, 2005.

Formulations and Use of Androgens in Women.pdf

The use of androgen therapy for postmenopausal women is discussed in this article. It suggests that the goal of androgen treatment should be to achieve normal premenopausal levels of testosterone, thus limiting adverse effects and adverse experiences.
Chu, M.C. & Lobo, R.A. (2004). Formulations and use of androgens in women. [Electronic version]. Mayo Clinic Proceedings, 79(4 Suppl.), S3-7. Retrieved May 18, 2005.

The Severity of Growth Hormone Deficiency Correlates with the Severity of Cardiac Impairment in 100 Adult Patients with Hypopituitarism: An Observational, Case-Control Study.pdf

The conclusion of this study was that cardiac performance is correlated with the GH status because significant impairment was found in patients with severe and partial GHD but not in non-GHD hypopituitary patients.
Colao, A., Di Somma, C., Cuocolo, A., Filippella, M., Rota, F., Acampa, W., et al. (2004). The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 89(12), 5998-6004. Retrieved November 18, 2005.

Insulin-Like Growth Factor-1 as a Vascular Protective Factor.pdf

According to this study, until recently, IGF-1 was considered a mediator of vascular disease. Increasing evidence indicates, instead, that IGF-1 protects against endothelial dysfunction, atherosclerotic plaque development, the metabolic syndrome, clinical instability, and ischemic myocardial damage.
Conti, E., Carrozza, C., Capoluongo, E., Volpe, M., Crea, F., Zuppi, C., et al. (2004). Insulin-like growth factor-1 as a vascular protective factor [Electronic version]. Circulation, 110(15), 2260-2265. Retrieved May 18, 2005.

The Serum Growth Hormone to Somatostatin Ratio is Skewed Upward in Rheumatoid Arthritis Patients.pdf

These results of this study indicated that symptomatic RA is associated with elevated serum growth hormone without concomitant changes in IGF-1 compared to individuals from the control group. Reduced somatostatin levels in older RA patients resulted in a skewed upward growth hormone to somatostatin ratio. It was concluded that the serum growth hormone to somatostatin ratio may be a useful surrogate marker of disease activity in symptomatic RA.
Denko, C.W. & Malemud, C.J. (2004). The serum growth hormone to somatostatin ratio is skewed upward in rheumatoid arthritis patients [Electronic version]. Frontiers in Bioscience, 9, 1660-1664. Retrieved October 25, 2005.

Low Testosterone Common in Type 2 Diabetes Study: 1 in 3 Diabetic Men May Suffer Low Sex Hormone Levels.pdf

A third of men with type 2 diabetes have low testosterone levels, a new study suggests.  Testosterone helps men reduce body fat and improves the way their bodies handle insulin. So low testosterone levels may have serious consequences for men with diabetes, suggests Sandeep Dhindsa, MD, of State University of New York at Buffalo.
DeNoon, D. (2004, December 1). Low testosterone common in type 2 diabetes  
study: 1 in 3 diabetic men may suffer low sex hormone levels. WebMD Health. Retrieved December 12, 2006.

Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes.pdf

Type 2 diabetes is associated with lower total testosterone levels in cross-sectional studies. However, it is not known whether the defect is primary or secondary. This article concludes that hypogonadotropic hypogonadism occurs commonly in type 2 diabetes.
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A. & Dandona, P. (2004). Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes [Electronic version]. Journal of Clinical Endocrinology and Metabolism, 89(11), 5462-5468. Retrieved January 19, 2005.

Review of the Book The Sexy Years: Discover the Hormone Connection: The Secret to Fabulous Sex, Great Health, and Vitality, for Women and Men.pdf

Review by Amazon.com of Suzanne Somers’ book The Sexy Years: Discover the Hormone Connection: The Secret to Fabulous Sex, Great Health, and Vitality, for Women and Men.
Lightner, J. (2004). [Review of the book The sexy years: Discover the hormone connection: the secret to fabulous sex, great health, and vitality, for women and men]. Retrieved September 10, 2004.

The Influence of Combined Supplementation of Glutamine and Recombinant Human Growth Hormone on the Protein Metabolism in Severely Burned Patients.pdf

This study focused on severely-burned patients.  It looked at combining administration of glutamine (Gln) and recombinant human growth hormone (rhGH) to see if it could be beneficial to the elevation of the plasma Gln level in these patients.
Lu, C.J., Lin, C., Xu, J.J., Zhang, P., Cao, G.Z. & Hong, B.S. (2004). [The influence of combined supplementation of glutamine and recombinant human growth hormone on the protein metabolism in severely burned patients] [Article in Chinese] [Electronic version]. Zhonghua Shao Shang Za Zhi [Chinese Journal of Burns], 20(4), 220-222. Retrieved May 18, 2005.

Low Androgenization Index in Elderly Women and Elderly Men with Alzheimer's Disease.pdf

The authors of this study investigated whether testosterone levels and testosterone availability differ between older lean subjects with and without Alzheimer's disease (AD). Sex hormone binding globulin (SHBG) and estradiol levels were higher, whereas the free androgenization index (FAI) was lower, in lean subjects with AD than in lean subjects without AD. Factors involved in the increase of SHBG secretion could have an important role in the lower testosterone availability of subjects with AD.
Paoletti, A.M., Congia, S., Lello, S., Tedde, D., Orru, M., et al. (2004). Low androgenization index in elderly women and elderly men with Alzheimer's disease [Electronic version]. Neurology. 62(2), 301-303. Retrieved September 27, 2005.

Diet Composition and the Risk of Type 2 Diabetes: Epidemiological and Clinical Evidence.pdf

This article concludes that new emphasis on prevention by multiple lifestyle modifications, including moderate changes in the composition of the habitual diet, might limit the dramatic increase in incidence of type 2 diabetes envisaged worldwide.
Parillo, M. & Riccardi, G. (2004). Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence [Electronic version]. The British Journal of Nutrition, 92(1), 7-19. Retrieved September 27, 2005.

Retrospective Analysis of the Impact of a Low Glycaemic Index Diet on Hospital Stay Following Coronary Artery Bypass Grafting: A Hypothesis.pdf

This study provides further support that carbohydrate and fat metabolism influence cardiac outcome and provides new evidence that dietary modification prior to coronary artery bypass surgery can shorten the hospital stay.
Patel, V.C., Aldridge, R.D., Leeds, A., Dornhorst, A. & Frost G.S. (2004). Retrospective analysis of the impact of a low glycaemic index diet on hospital stay following coronary artery bypass grafting: a hypothesis [Electronic version]. Journal of Human Nutrition & Dietetics, 17(3), 241-247. Retrieved May 17, 2005.

Risks of Testosterone-Replacement Therapy and Recommendations for Monitoring.pdf

According to this study, hypogonadism affects an estimated 2 million to 4 million men in the United States; its prevalence increases with age. However, it has been estimated that only 5 percent of affected men currently receive treatment. Recent interest in testosterone therapy has been fueled not only by increased medical awareness of the effects of hypogonadism, but also by media attention regarding hormone-replacement therapy in both men and women, the marketing of new topical testosterone formulations, and the desire of "baby boomers" to maintain vigor and health into their more mature years.
Rhoden, E.L. & Morgentaler, A. (2004). Risks of testosterone-replacement therapy and recommendations for monitoring [Electronic version]. The New England Journal of Medicine, 350(5), 482-492. Retrieved September 27, 2005.

Growth Hormone Replacement Therapy Appears Safe in Long Term.pdf

Rates of death, cancers, and intracranial tumor growth do not appear to be increased by growth hormone replacement therapy in adults, Mark L. Hartman, M.D., reported at the 12th International Congress of Endocrinology.
Tucker, M.E. (2004). Growth hormone replacement therapy appears safe in long term. Family Practice News, 34(21). Retrieved May 17, 2005.

Reduced Longevity in Untreated Patients with Isolated Growth Hormone Deficiency.pdf

The aim of this study was to analyze the impact of untreated GHD on life span. Hereditary dwarfism was recognized in 11 subjects.
Besson, A., Salemi, S., Gallati, S., Jenal, A., Horn, R., et al. (2003). Reduced longevity in untreated patients with isolated growth hormone deficiency [Electronic version]. The Journal of Clinical Endocrinology & Metabolism, 88(8), 3664-3667. Retrieved September 26, 2005.

Effects of Testosterone Administration on Fat Distribution, Insulin Sensitivity, and Atherosclerosis Progression.pdf

According to this article, testosterone infusion increases coronary blood flow. Similarly, testosterone replacement retards atherogenesis in experimental models of atherosclerosis. However, the long-term risks and benefits of testosterone administration in human immunodeficiency virus-infected men with fat redistribution syndrome have not been studied in randomized clinical trials.
Bhasin, S. (2003). Effects of testosterone administration on fat distribution, insulin sensitivity, and atherosclerosis progression [Electronic version]. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 37(Suppl. 2), S142-9. Retrieved September 27, 2005.

Testosterone and Atherosclerosis.pdf

This article concludes that the overall effect of administration of testosterone on cardiovascular-disease risk is difficult to assess because androgens have such an extraordinary array of effects in vivo.
Eckardstein, A. & Wu, F.C. (2003). Testosterone and atherosclerosis [Electronic version]. Growth Hormone & IGF Research: Official Journal of the Growth Hormone Research Society and the International IGF Research Society, 13(Suppl. A), S72-84. Retrieved September 27, 2005.

Dehydroepiandrosterone Replacement in Healthy Men with Age-Related Decline of DHEA-S: Effects on Fat Distribution, Insulin Sensitivity and Lipid Metabolism.pdf

The results of this study did not reveal any significant changes in study parameters, apart from a statistically significant increase in DHEA-S levels after therapy with active substance.
Jedrzejuk, D., Medras, M., Milewicz, A. & Demissie, M. (2003). Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism [Electronic version]. The Aging Male, 6(3), 151-156. Retrieved December 7, 2005.

Effects of Growth Hormone Secretion on Body Composition in Patients with Crohn’s Disease.pdf

This study states that although serum GH levels were similar in the two groups, GH contributed significantly to the abdominal fat measurements. These data show that GH has an important role in modulating visceral fat distribution in patients with Crohn's disease.
Katznelson, L., Fairfield, W.P., Zeizafoun, N., Sands, B.E., Peppercorn, M.A., Rosenthal, D.I., et al. (2003). Effects of Growth Hormone secretion on body composition in patients with Crohn’s disease. The Journal of Clinical Endocrinology and Metabolism, 88(11), 5468-5472. Retrieved December 7, 2005.

Change of Protein Catabolism and Immunocompetence in Severely Burned Patients After Operations and the Therapeutic Effect of Recombinant Human Growth Hormone.pdf

Thirty-eight severely burned patients were studied to investigate the changes in protein catabolism and immunocompetence in such patients postoperatively. It also observed the therapeutic effect of recombinant human growth hormone (rhGH) in these patients. It concluded that nutrition support and rhGH treatment may produce rapid improvement for the patients with regard to their conditions.
Lai, W., Chen, H.D., Zheng, S.Y., Gao, H. & Xiong, B. (2003). [Change of protein catabolism and immunocompetence in severely burned patients after operations and the therapeutic effect of recombinant human growth hormone] [Article in Chinese] [Electronic version]. Di Yi Jun Yi Da Xue Xue Bao [Academic Journal of the First Medical College of PLA], 23(10), 1112-1114. Retrieved May 18, 2005.

Dehydroepiandrosterone Sulfate Levels Associated with Decreased Malaria Parasite Density and Increased Hemoglobin Concentration in Pubertal Girls from Western Kenya.pdf

These findings of this study support the hypothesis that host pubertal development, independent of age and, by proxy, cumulative exposure, is necessary for maximal expression of resistance to malarial infection and morbidity, as assessed by hemoglobin level.
Leenstra, T., ter Kuile, F.O., Kariuki, S.K., Nixon, C.P., Oloo, A.J., Kager, P.A., et al. (2003). Dehydroepiandrosterone sulfate levels associated with decreased malaria parasite density and increased hemoglobin concentration in pubertal girls from western Kenya [Electronic version]. The Journal of Infectious Diseases, 188(2), 297-304. Retrieved December 7, 2005.

Growth Hormone Protects Human Lymphocytes from Irradiation-Induced Cell Death.pdf

According to this study, undesired effects of cancer radiotherapy mainly affect the hematopoietic system. Growth hormone (GH) participates in both hematopoiesis and modulation of the immune response.
Lempereur, L., Brambilla, D., Scoto, G.M., D'Alcamo, M., Goffin, V., Crosta, L., et al. (2003). Growth hormone protects human lymphocytes from irradiation-induced cell death [Electronic version]. British Journal of Pharmacology, 138(8), 1411-1416. Retrieved December 7, 2005.

Impact of Perioperative Treatment of Recombinant Human Growth Hormone on Cell Immune Function and Intestinal Barrier Function: Randomized, Double-Blind, Controlled Trial.pdf

Twenty patients undergoing abdominal surgery participated in this placebo-controlled randomized double-blind trial.  Each patient was given human growth hormone subcutaneously for a period of days leading up to and following the operation. 
Liu, W., Jiang, Z., Wang, X., Shu, H., Cui, W. & Wilmore, D.W. (2003). Impact of perioperative treatment of recombinant human growth hormone on cell immune function and intestinal barrier function: randomized, double-blind, controlled trial [Electronic version]. World Journal of Surgery, 27(4), 412-415. Retrieved May 18, 2005.

The Study of Phenolic Compounds as Natural Antioxidants in Wine.pdf

The relationship between antioxidant activity of phenolic comounds, as hydrogen donating free radical scavengers, and their chemical structures was studied. Furthermore, the total antioxidant activity of the wines investigated was well correlated with phenol content. Thus, the results confirm that red wine polyphenols are, in vitro, significant antioxidants.
Lopez-Velez, M., Martinez-Martinez, F. & Del Valle-Ribes, C. (2003). The study of phenolic compounds as natural antioxidants in wine [Electronic version]. Critical Reviews in Food Science and Nutrition, 43(3), 233-244. Retrieved November 1, 2005.

Testosterone as a Protective Factor Against Atherosclerosis--Immunomodulation and Influence Upon Plaque Development and Stability.pdf

In this article, the authors discuss some of the mechanisms involved in atherosclerotic coronary artery disease and the putative link between testosterone deficiency and atheroma formation. They present the hypothesis that the immune-modulating properties of testosterone may be important in inhibiting atheroma formation and progression to acute coronary syndrome.
Malkin, C.J., Pugh, P.J., Jones, R.D., Jones, T.H. & Channer, K.S. (2003). Testosterone as a protective factor against atherosclerosis--immunomodulation and influence upon plaque development and stability [Electronic version]. The Journal of Endocrinology, 178(3), 373-380. Retrieved September 27, 2005.

Growth Hormone and Insulin-Like Growth Factor-1 Concentrations in Women with Fibromyalgia.pdf

In this sample of premenopausal women with FM, the activity of the GH-IGF-1 axis was similar to that of healthy controls. Increases in age and obesity were both strongly associated with lower activity of this axis, suggesting that these factors must be considered when studying activity of the GH-IGF-1 axis in FM.
McCall-Hosenfeld, J.S., Goldenberg, D.L., Hurwitz, S. & Adler, G.K. (2003). Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia [Electronic version]. The Journal of Rheumatology, 30(4), 809-814. Retrieved September 26, 2005.

Endogenous Sex Hormones and Cardiovascular Disease in Men.pdf

The purpose of this article is to summarize the evidence currently available on the association between endogenous sex hormones and cardiovascular disease in males. Published studies dealing with the relationship between circulating levels of sex hormones and cardiovascular disease in males were reviewed. The studies reviewed in this article suggest that circulating endogenous sex hormones and estrogens have a neutral or beneficial effect on cardiovascular disease in men.
Muller, M. van der Schouw, Y.T.,Thijssen, J.H. & Grobbee, D.E. (2003). Endogenous sex hormones and cardiovascular disease in men [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 88(11), 5076-5086. Retrieved September 27, 2005.

Testosterone Replacement Therapy in Hypogonadal Men at High Risk for Prostate Cancer: Results of 1 year of Treatment in Men with Prostatic Intraepithelial Neoplasia.pdf

This study concludes that after 1 year of testosterone replacement therapy (TRT) men with prostatic intraepithelial neoplasia (PIN) do not have a greater increase in PSA or a significantly increased risk of cancer than men without PIN. These results indicate that TRT is not contraindicated in men with a history of PIN.
Rhoden, E.L. & Morgentaler, A. (2003). Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: Results of 1 year of treatment in men with prostatic intraepithelial neoplasia. The Journal of Urology, 170(6, Part 1 of 2), 2348-2351. Retrieved September 27, 2005.

Cytokines, Insulin-Like Growth Factor 1, Sarcopenia, and Mortality in Very Old Community-Dwelling Men and Women: The Framingham Heart Study.pdf

This study concludes that greater levels or production of the catabolic cytokines TNF-alpha and interleukin 6 are associated with increased mortality in community-dwelling elderly adults, whereas IGF-1 levels had the opposite effect.
Roubenoff, R., Parise, H., Payette, H.A., Abad, L.W., D’Agostino, R., et al. (2003). Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study [Electronic version]. The American Journal of Medicine, 115(6), 429-435. Retrieved September 19, 2005.

Serum Free Testosterone in Men with Coronary Artery Atherosclerosis.pdf

The aim of this study was to determine whether levels of serum free testosterone differ between men with and without coronary artery disease. It concluded that a low level of free testosterone may be related to the development of coronary artery disease.
Sieminska, L., Wojciechowska, C., Swietochowska, E., Marek, B., Kos-Kudla, B., et al. (2003). Serum free testosterone in men with coronary artery atherosclerosis [Electronic version]. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 9(5), CR162-6. Retrieved September 27, 2005.

Recombinant Human Growth Hormone Treatment in Elderly Patients Undergoing Elective Total Hip Replacement.pdf

This study concluded that in elderly patients undergoing total hip replacement, preoperative GH treatment results in improvements in lean body mass and skeletal muscle mass that are sufficient to offset postoperative losses.  The treatment may also preserve or improve muscle strength and postoperative walking ability.
Weissberger, A.J., Anastasiadis, A.D., Sturgess, I., Martin, F.C., Smith, M.A. & Sonksen, P.H. (2003). Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement [Electronic version]. Clinical Endocrinology (Oxford), 58(1), 99-107. Retrieved May 17, 2005.

Inverse Relationship Between Total Testosterone and Anti-Oxidized Low Density Lipoprotein Antibody Levels in Ageing Males.pdf

This study showed that in multiple regression analysis only testosterone level was independently associated with anti-oxLDL Ab. These data suggest a that fall of testosterone concentration in ageing men can influence either oxidative modification of LDL or the immune response to these lipoproteins which may be important in the pathogenesis of atherosclerosis.
Barud, W., Palusinski, R.,Beltowski, J. & Wojcicka, G. (2002). Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males [Electronic version]. Atherosclerosis, 164(2), 283-288. Retrieved September 27, 2005.

Immune Function During GH Treatment in GH-Deficient Adults; An 18-Month Randomized, Placebo-Controlled, Double-Blinded Trial.pdf

Insulin-like growth factor-I (IGF-I) is regulated by human growth hormone (hGH) and mediates many of the biological functions of human growth hormone (hGH).  It is known that human growth hormone (hGH) levels decline with age.  This study was to determine whether a decrease in the availability of insulin-like growth factor-I (IGF-I) might contribute to age-related changes in immune functions.  The results indicated that a reduction in immunocompetence may be one of the consequences of reduced insulin-like growth factor-I (IGF-I) levels in human aging. 
Sneppen, S.B., Mersebach, H., Ullum, H. & Feldt-Rasmussen, U. (2002). Immune function during GH treatment in GH-deficient adults; an 18-month randomized, placebo-controlled, double-blinded trial [Electronic version]. Clinical Endocrinology (Oxford), 57(6), 787-792. Retrieved July 28, 2003.

Severely Burned Patients After Surgery: Recombinant Human Growth Hormone Therapy its Metabolic Effects.pdf

This study concludes that recombinant human growth hormone (rhGH) has a beneficial effect on metabolism in patients who are severely burned.  Hyperglycemia, however, is apt to occur and water, Na(+), Cl(-) retention are suggested.  Fifty patients were studied.
Chai, J., Hao, D., Wu, Y., Shen, C., Guo, Z. & Sheng, Z. (2002). [Severely burned patients after surgery: recombinant human growth hormone therapy its metabolic effects] [Article in Chinese] [Electronic version]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery], 40(2), 107-111. Retrieved May 18, 2005.

The Effects of Recombinant Human Growth Hormone on the Metabolism of Branch Chain Amino Acid in Severely Burned Patients.pdf

Fifty severely-burned patients were enrolled in this study, the aim of which was to explore the effects of recombinant human growth hormone (rhGH) on the metabolism of branch chain amino acid when applied postoperatively.
Chai, J., Hao, D., Wu, Y., Shen, C. & Sheng, Z. (2002). [The effects of recombinant human growth hormone on the metabolism of branch chain amino acid in severely burned patients] [Article in Chinese] [Electronic version]. Zhonghua Shao Shang Za Zhi [Chinese Journal of Burns], 18(4), 229-31. Retrieved May 18, 2005.

The Influence of Recombinant Human Growth Hormones on the Systemic Metabolism After Severe Burn.pdf

The conclusion of this study involving twenty-four burn patients was that a small dose of recombinant human growth hormone could promote systemic protein synthesis with no side effects on blood glucose levels.
Chen, Z., Gu, C., Wang, Z., Ye, X., Wang, X., Li, H., Shen, Y. & Li, J. (2002). [The influence of recombinant human growth hormones on the systemic metabolism after severe burn] [Article in Chinese] [Electronic version]. Zhonghua Shao Shang Za Zhi [Chinese Journal of Burns], 18(3), 183-185. Retrieved May 18, 2005.

The Cardiovascular Risk of Adult GH Deficiency (GHD) Improved After GH Replacement and Worsened in Untreated GHD: A 12-Month Prospective Study.pdf

This study concluded that 12 months of GH replacement normalized IGF-I and improved lipid profile and cardiac performance in adult GHD patients. A similar period of GH deprivation induced a further impairment of lipid profile and cardiac performance. This finding strongly supports the need of GH replacement in adult GHD patients.
Colao, A., di Somma, C., Pivonello, R., Cuocolo, A., Spinelli, L., et al. (2002).  The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study [Electronic version]. The Journal of Clinical Endocrinology & Metabolism, 87(3), 1088-1093. Retrieved September 26, 2005.

Low Levels of Endogenous Androgens Increase the Risk of Atherosclerosis in Elderly Men:  The Rotterdam Study.pdf

The authors of this study concluded that they found an independent inverse association between levels of testosterone and aortic atherosclerosis in men. In women, positive associations between levels of testosterone and aortic atherosclerosis were largely due to adverse cardiovascular disease risk factors.
Hak, A.E., Witteman, J.C., de Jong, F.H., Geerlings, M.I., Hofman, A. & Pols, H.A. (2002). Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men:  the Rotterdam study [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 87(8), 3632-3639. Retrieved December 7, 2005.

Reduced Microvascular Perfusion and Reactivity in Adult GH Deficient Patients is Restored by GH Replacement.pdf

Thirteen adult patients with severe GH-deficiency (GHD) were evaluated in this study.  The objective was to evaluate the microcirculation and vascular reactivity in a GHD state before and during GH replacement.
Hana, V., Prazny, M., Marek, J., Skrha, J. & Justova, V. (2002). Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement [Electronic version]. European Journal of Endocrinology/European Federation of Endocrine Societies, 147(3), 333-337. Retrieved May 18, 2005.

Growth Hormone Therapy for Adults: Not Ready for Prime Time?.pdf

This article states that long-term studies in patients receiving appropriate comprehensive management for other hormonal deficiencies and for concomitant abnormalities will be required to convince physicians of the utility and safety of growth hormone replacement therapy.
Isley, W.L. (2002). Growth hormone therapy for adults: not ready for prime time? [Electronic version]. Annals of Internal Medicine, 137(3), 190-196. Retrieved September 26, 2005.

Low Serum Insulin-Like Growth Factor I is Associated with Increased Risk of Ischemic Heart Disease: A Population-Based Case-Control Study.pdf

This study concluded that individuals without IHD but with low circulating IGF-I levels and high IGFBP-3 levels have significantly increased risk of developing IHD during a 15-year follow-up period. Our findings suggest that IGF-I may be involved in the pathogenesis of IHD.
Juul, A., Scheike, T., Davidsen, M., Gyllenborg, J. & Jorgensen, T. (2002). Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study [Electronic version]. Circulation, 106(8), 939-944. Retrieved December 7, 2005.

The Effect of Dehydroepiandrosterone on Hemorrhage-Induced Suppression of Cellular Immune Function.pdf

This study concluded that DHEA administration improves cellular immune function after hemorrhage and may therefore be beneficial in patients with hemorrhagic shock.
Oberbeck, R., Nickel, E., von Griensven, M., Tschernig, T., Wittwer, T., Schmitz, D., et al. (2002). The effect of dehydroepiandrosterone on hemorrhage-induced suppression of cellular immune function [Electronic version]. Intensive Care Medicine, 28(7), 963-968. Retrieved December 7, 2005.

Association of IGF-I Levels with Muscle Strength and Mobility in Older Women.pdf

This article summarizes that in a study population including frail and healthy older women, low IGF-I levels were associated with poor knee extensor muscle strength, slow walking speed, and self-reported difficulty with mobility tasks. These findings suggest a role for IGF-I in disability as well as a potential target population for interventions to raise IGF-I levels.
Cappola, A.R., Bandeen-Roche, K., Wand, G.S., Volpato, S. & Fried, L.P. (2001). Association of IGF-I levels with muscle strength and mobility in older women [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 86(9), 4139-4146. Retrieved September 28, 2005.

Safety Aspects of Pharmacological GH Therapy in Adults.pdf

The objective of the study was to assess the safety of large doses of rhGH therapy in human adults. Well-conducted and reported randomized trials are still needed to inform practice as to whether GH administration will be safe in specific illness categories.
Carroll, P.V. & Van den Berghe, G. (2001). Safety aspects of pharmacological GH therapy in adults [Electronic version]. Growth Hormone & IGF Research, 11(3), 166-172. Retrieved January 3, 2006.

Improved Cardiovascular Risk Factors and Cardiac Performance After 12 Months of Growth Hormone (GH) Replacement in Young Adult Patients with GH Deficiency.pdf

This article concludes that GH replacement for 12 months significantly improved lipid profile, decreased fibrinogen levels, and increased LVMi and LVEF in young adults with co- or ao-GHD. However, lipid profile, fibrinogen levels, and systolic function remained abnormal compared with those in age- and sex-matched controls, suggesting that a longer period of GH replacement is necessary to normalize cardiovascular parameters and reverse the cardiovascular risk of these patients.
Colao, A., di Somma, C., Cuocolo, A., Spinelli, L., Tedesco, N., et al. (2001).  Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency [Electronic version].  The Journal of Clinical Endocrinology & Metabolism, 86(5), 1874-1881. Retrieved September 26, 2005.

Prostate Cancer Risk and Serum Levels of Insulin and Leptin: A Population-Based Study.pdf

The results of this study suggest that serum insulin levels may influence the risk of prostate cancer in Chinese men. Further research, especially prospective studies, is needed to confirm these findings in high-risk populations and to clarify the underlying mechanisms involved.
Hsing, A.W., Chua, S., Jr., Gao, Y.T., Gentzschein, E., Chang, L., et al. (2001). Prostate cancer risk and serum levels of insulin and leptin: a population-based study [Electronic version]. Journal of the National Cancer Institute, 93(10), 783-789. Retrieved September 27, 2005.

Clinical Perspective - Acromegaly and Cancer: Not a Problem?.pdf

This study discusses how uncontrolled acromegaly may provide a growth advantage to concurrently occurring neoplasms in these patients; and based upon experimental information, cancer in a patient with acromegaly and uncontrolled GH levels will likely be more aggressive, with potentially increased cancer-associated morbidity and mortality. However, there is no clear evidence for enhanced de novo cancer initiation in acromegaly and, as yet, no direct proven causal relationship of acromegaly with malignant disease.
Melmed, S. (2001). Clinical perspective - Acromegaly and cancer: not a problem? [Electronic version]. The Journal of Clinical Endocrinology & Metabolism, 86(7), 2929-2934. Retrieved September 26, 2005.

Dehydroepiandrosterone Decreases Mortality Rate and Improves Cellular Immune Function During Polymicrobial Sepsis.pdf

These results of this study demonstrate that DHEA administration leads to an increased survival following a septic challenge. The immunoenhancing effect of DHEA is accompanied by a reduction of TNF-alpha release and an improved activity of T-cellular immunity. DHEA administration may, therefore, be beneficial in systemic inflammation.
Oberbeck, R., Dahlweid, M., Koch, R., van Griensven, M., Emmendorfer, A., et al. (2001). Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis [Electronic version]. Critical Care Medicine, 29(2), 380-384. Retrieved September 13, 2005.

Personal Business; Trying to Roll Back the Biological Clock, for a Price.pdf

This article, written soon after September 11th, says that Americans have been re-evaluating their priorities since the attacks, and for some people that means paying closer attention to their health. There has even been a rise in interest in so-called anti-aging clinics.  It discusses several clinics, including Cenegenics.
Siwolop, S. (2001, October 21). Personal business; trying to roll back the biological clock, for a price [Electronic version]. The New York Times. Retrieved October 31, 2005.

Diagnosis and Management of Growth Hormone Deficiency in Adults.pdf

According to this article, treatment with growth hormone reverses abnormalities in body composition and may reduce cardiovascular risk factors; however, the long-term treatment outcomes regarding mortality, the incidence of cardiovascular disease, bone fractures, tumor development, and recurrence are not known. Longer prospective clinical studies are needed. The major manufacturers of growth hormone have initiated postmarketing surveillance databases to monitor the safety of growth hormone treatment.
Stavrou, S. & Kleinberg, D.L. (2001). Diagnosis and management of growth hormone deficiency in adults [Electronic version]. Endocrinology and Metabolism Clinics of North America, 30(3), 545-563. Retrieved September 26, 2005.

Low-Dose Transdermal Testosterone Therapy Improves Angina Threshold in Men with Chronic Stable Angina: A Randomized, Double-Blind, Placebo-Controlled Study.pdf

This study concluded that low-dose supplemental testosterone treatment in men with chronic stable angina reduces exercise-ind